medindexer
Knowledge Centre
price estimate

What Does OmnifyXR® Interventional Suite Cost?

May 5, 2026· 6 min read· AI-generated

What Does OmnifyXR® Interventional Suite Cost?

A procurement guide to an emerging interventional augmented-reality platform with limited public pricing data

OmnifyXR is currently available in the United States , but unlike mature medical device markets, the system integrates exclusively with GE HealthCare interventional X-ray systems such as the Allia IGS family or Innova IGS family with AutoRight . This exclusive partnership and early-market status mean that no public manufacturer list prices, GSA schedule pricing, or aggregated hospital purchase data currently exist. Institutions acquiring OmnifyXR today negotiate directly with GE HealthCare and MediView sales representatives.

What the typical range is

Pricing is not publicly available.

As of May 2026, MediView XR and GE HealthCare do not publish standard list prices or tiered pricing models for OmnifyXR. This is typical for first-generation integrated visualization systems in a nascent market segment. Institutions should expect to obtain quotes on a case-by-case basis through direct sales channels. Without aggregate data from a minimum viable install base, cost drivers cannot yet be reliably indexed.

What pushes price up — features, certifications, support tier

The system includes a heads-up display (HUD) headset that holographically displays multiple imaging video streams; clinicians can simultaneously display up to four video streams (such as Live Fluoroscopy, Reference Image, Advantage Workstation Image, Ultrasound, and Hemodynamics) and customize size, angle, and orientation .

Infrastructure integration complexity will likely be a major cost driver. The OmnifyXR solution provides a heads-up, augmented reality display of interventional x-ray imaging systems using Microsoft's latest HoloLens technology . Licensing, initial suite configuration, and IT integration (network architecture, DICOM routing, sterile environment compliance) add variable costs that will scale with interventional suite complexity. Facilities operating multiple GE interventional platforms may negotiate volume pricing, but this is speculative without public guidance.

Regulatory status will affect deployment scope. OmnifyXR does not require FDA 510(k) clearance as a standalone system—it operates as adjunctive software to existing cleared X-ray platforms. This streamlined path reduces regulatory overhead compared to standalone visualization devices, but institutions should verify CE marking status and regional clearances before committing.

What pushes price down — refurbished, older generation, lease, GPO contracts

Because OmnifyXR launched clinically in June 2024 with the first installation at North Star Vascular and Interventional in Minneapolis, there are no used units or refurbished systems on secondary markets yet. Expect a 2–3 year lag before institutional trade-ins materialize.

Leasing options: No public information exists on whether MediView or GE HealthCare offer lease-to-own or operational expense models. For emerging systems, vendors often prefer capital sales to establish install base and lock in strategic accounts. Institutions should explicitly ask whether off-balance-sheet financing (operating leases under ASC 842) is available, as this can defer cash impact.

Group Purchasing Organization (GPO) contracts: OmnifyXR is not yet listed on major GPO contracts (Premier, Novamed, Medline) as far as public records show. Given its exclusive GE partnership and early adoption phase, GPO coverage may be years away. Hospitals with GE Prime contracts should discuss whether OmnifyXR discounts are embedded in existing imaging agreements.

Hidden costs — install, training, calibration, consumables, service contracts

Installation and integration: Site preparation, network infrastructure, and suite reconfiguration are not included in typical equipment quotes. Expect an additional 4–8 weeks of planning and validation. Institutions with older interventional suites may incur unexpected rewiring or server upgrades to support real-time holographic rendering.

Training: The system is designed to allow remote collaboration, consultation, training, proctoring and support . Manufacturer-led training (on-site and remote) is usually provided in the first year, but continuing education for turnover staff and new procedures will require internal scheduling and potential external vendor support beyond the initial contract.

Headset and peripherals: OmnifyXR headsets are Microsoft HoloLens 2 devices. The solution provides a heads-up, augmented reality display using Microsoft's latest HoloLens technology . Replacement headsets, battery degradation (estimated 2–3 year lifespan per unit), and environmental sensors incur incremental cost. Do not assume purchase price covers headset replacement or warranty extensions.

Service contracts: Ask explicitly whether quote includes:

  • Annual software maintenance and updates
  • Technical support response times (24/7 vs. business hours)
  • Hardware repair vs. replacement for HoloLens failures
  • Spare parts inventory (headsets, compute modules, calibration tools)

Consumables: Workflows involving frequent headset changeover (e.g., multi-room interventional centers) will stress optical components. Clarify whether routine maintenance (lens cleaning, battery conditioning) is vendor-supported or falls to in-house biomedical teams.

How to negotiate — concrete tactics

  1. Clarify the bundle scope. Ask whether the quote includes:

    • HoloLens 2 headsets (singular or multi-unit license)
    • Integration with your specific GE imaging platforms (Allia vs. Innova models)
    • Initial software licensing (1, 3, or 5 years)
    • Training hours (on-site instructor, remote, recorded modules)

  2. Request volume pricing. If your health system operates multiple interventional suites, negotiate a single system-wide price across installations. Early adopters have leverage because MediView needs reference installations for market validation.

  3. Negotiate service tiers upfront. Demand a tiered SLA with defined uptime targets (e.g., 95% availability during clinical hours). Early systems will experience firmware issues and calibration drift; ensure vendor support includes rapid response and on-site troubleshooting.

  4. Push for trade-in or upgrade clauses. Secure language that allows you to upgrade HoloLens hardware to future generations (HoloLens 3, etc.) without purchasing a full new system. Request a price-hold guarantee if hardware updates are released within 18–24 months.

  5. Ask about financing models explicitly. If capital budgets are constrained, request an operational lease proposal. Vendor hesitation signals that leasing is not yet a standard offering—use that as negotiating leverage for price concessions on capital purchase.

  6. Benchmark against competing AR platforms. Research other interventional AR systems (e.g., Augmedics SpineGuide for orthopedic navigation) to understand the broader market. OmnifyXR is specialized to interventional radiology, but adjacent XR surgical platforms may provide context for reasonable pricing.

When the price feels off — red flags

  • Vendor quotes a price but refuses to itemize installation, training, or support costs. This signals they are still working out their go-to-market model. Request a detailed cost breakdown, and be skeptical of "all-in" figures.

  • The quote locks you into a multi-year software subscription with non-cancellation terms. Given that OmnifyXR is brand-new, demanding 5-year commitments is unreasonable. Negotiate annual or 3-year renewal options.

  • Support is limited to remote troubleshooting only, with no on-site engineer option. HoloLens optical calibration and spatial registration require hands-on diagnostics. If the vendor cannot commit to on-site support within 48–72 hours, operational reliability will suffer.

  • The quote includes OmnifyXR but omits GE imaging system licensing or upgrades. Clarify whether you are buying OmnifyXR as a pure add-on or if GE's Allia/Innova platform licensing is included. This distinction will affect total cost.

  • Vendor claims pricing is "market standard" without showing comparables. OmnifyXR pricing is not yet benchmarked. Any vendor citing precedent without naming reference accounts is deflecting. Push for transparency.

Sources

Editor's Note

MediSource's pricing database has not yet accumulated sufficient OmnifyXR quotes to publish aggregate cost ranges. This article will be updated as institutional purchase data becomes available. Procurement teams are encouraged to share anonymized pricing intelligence to accelerate market transparency. For current quotes and integration estimates, contact GE HealthCare or MediView directly.

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.

Ask anything about this article. The AI answers using only what's on this page — if the answer isn't in the article, it will tell you. Each question is fresh (no chat history kept).